Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.
Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH) PR Newswire CARLSBAD, Calif., July 2, 2024 - In a preclinical HCH model, TYRA-300...
Tyra Biosciences to Present at Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., May 23, 2024 CARLSBAD, Calif., May 23, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.11 | -0.554435483871 | 19.84 | 21.64 | 19.03 | 104578 | 20.22568173 | CS |
4 | 2.53 | 14.7093023256 | 17.2 | 21.64 | 15.28 | 126177 | 17.90983596 | CS |
12 | 3.96 | 25.1109701966 | 15.77 | 21.64 | 15.28 | 137628 | 18.07446899 | CS |
26 | 6.49 | 49.0181268882 | 13.24 | 21.64 | 12.34 | 137182 | 17.53963083 | CS |
52 | 3.46 | 21.2661339889 | 16.27 | 21.64 | 10.38 | 102049 | 16.18190183 | CS |
156 | -10.17 | -34.0133779264 | 29.9 | 31.36 | 4.93 | 103234 | 14.98914995 | CS |
260 | -10.17 | -34.0133779264 | 29.9 | 31.36 | 4.93 | 103234 | 14.98914995 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.